Aquestive Therapeutics, Inc. AQST Contract Assets, Net
Contract Assets, Net at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsInventory.
The official record: Aquestive Therapeutics, Inc.’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s contract assets, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s contract assets, net?
- Aquestive Therapeutics, Inc. (AQST) reported contract assets, net of $435K in Q4 2025.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s contract assets, net?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s contract assets, net has grown at a 12.3% compound annual growth rate (CAGR), from $345K to $435K.
- What does contract assets, net mean?
- This represents the entity's right to consideration in exchange for goods or services that have been transferred to a customer, where the right is conditional on something other than the passage of time. It reflects revenue recognized for performance obligations satisfied before the customer is billed. This metric is critical for assessing the timing of revenue recognition and potential credit risk associated with unbilled receivables.